title: [Nivolumab (Anti-PD-1 antibody; ONO-4538/BMS-936558) in renal cancer].
abstract: The effect of the anti-PD-1 antibody, nivolumab (ONO-4538/BMS-936558) on advanced renal cancer is promising. The present manuscript summarizes the use of this new drug in immunotherapy for renal cancer.
authors.affiliation: Dept. of Urology, Hamamatsu University School of Medicine.
authors.forename: Seiichiro
authors.initials: S
authors.lastname: Ozono
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D017326:Clinical Trials, Phase III as Topic; D018450:Disease Progression; D006801:Humans; D007680:Kidney Neoplasms / Q000188:drug therapy* / Q000473:pathology; D000077594:Nivolumab
chemical_list: D000911:Antibodies, Monoclonal; D000077594:Nivolumab